480 related articles for article (PubMed ID: 18521512)
1. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
[TBL] [Abstract][Full Text] [Related]
2. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
[TBL] [Abstract][Full Text] [Related]
3. G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece.
Rallidis LS; Gialeraki A; Fountoulaki K; Politou M; Sourides V; Travlou A; Lekakis I; Kremastinos DT
Thromb Res; 2010 Jan; 125(1):34-7. PubMed ID: 19409601
[TBL] [Abstract][Full Text] [Related]
4. Factor XIII val34leu and the risk of myocardial infarction.
Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
[TBL] [Abstract][Full Text] [Related]
5. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
[TBL] [Abstract][Full Text] [Related]
8. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
[TBL] [Abstract][Full Text] [Related]
9. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
10. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
11. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
Mills JD; Mansfield MW; Grant PJ
Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction.
Li YH; Chen JH; Tsai WC; Chao TH; Guo HR; Tsai LM; Wu HL; Shi GY
Thromb Haemost; 2002 Jan; 87(1):86-91. PubMed ID: 11848462
[TBL] [Abstract][Full Text] [Related]
14. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women.
Pischon T; Pai JK; Manson JE; Hu FB; Rexrode KM; Hunter D; Rimm EB
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1654-8. PubMed ID: 15920035
[TBL] [Abstract][Full Text] [Related]
17. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E, CI and B gene polymorphisms in a sample of patients with coronary heart disease in the Kuwaiti population.
Al-Bustan SA; Alkhalaf M; Al-Rashdan I; Al-Otaibi S; Al-Baker E; Balding D; Alnaqeeb MA
Med Princ Pract; 2009; 18(4):294-9. PubMed ID: 19494537
[TBL] [Abstract][Full Text] [Related]
19. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.
Vokó Z; Bereczky Z; Katona E; Adány R; Muszbek L
Thromb Haemost; 2007 Mar; 97(3):458-63. PubMed ID: 17334514
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]